These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38369020)
1. Current State of Minitablet Product Design: A Review. Meruva S; Singaraju AB; Vinjamuri BP; Ternik R; Stagner WC J Pharm Sci; 2024 May; 113(5):1123-1154. PubMed ID: 38369020 [TBL] [Abstract][Full Text] [Related]
2. Paediatric solid oral dosage forms for combination products: Improving in vitro swallowability of minitablets using binary mixtures with pellets. Avila-Sierra A; Lavoisier A; Timpe C; Kuehl P; Wagner L; Tournier C; Ramaioli M Eur J Pharm Sci; 2023 Aug; 187():106471. PubMed ID: 37210000 [TBL] [Abstract][Full Text] [Related]
3. Evidence of acceptability of oral paediatric medicines: a review. Mistry P; Batchelor H; J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471 [TBL] [Abstract][Full Text] [Related]
4. Minitablets current use and future opportunities - An APV course on manufacturing, packaging, characterization and use of minitablets. Page S; Rode T; Breitkreutz J; Wagner-Hattler L Eur J Pharm Biopharm; 2024 Jun; 199():114294. PubMed ID: 38636884 [TBL] [Abstract][Full Text] [Related]
5. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial. Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451 [TBL] [Abstract][Full Text] [Related]
6. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial. Klingmann V; Linderskamp H; Meissner T; Mayatepek E; Moeltner A; Breitkreutz J; Bosse HM J Pediatr; 2018 Oct; 201():202-207.e1. PubMed ID: 29960767 [TBL] [Abstract][Full Text] [Related]
7. A novel soft robotic pediatric in vitro swallowing device to gain insights into the swallowability of mini-tablets. Lavoisier A; Avila-Sierra A; Timpe C; Kuehl P; Wagner L; Tournier C; Ramaioli M Int J Pharm; 2022 Dec; 629():122369. PubMed ID: 36351507 [TBL] [Abstract][Full Text] [Related]
8. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Aleksovski A; Dreu R; Gašperlin M; Planinšek O Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881 [TBL] [Abstract][Full Text] [Related]
9. Dispensing of minitablets - Has the problem been resolved? Hejduk A; Lulek J Int J Pharm; 2022 May; 619():121666. PubMed ID: 35339634 [TBL] [Abstract][Full Text] [Related]
10. Determination of healthcare resource and cost implications of using alternative sodium valproate formulations in the treatment of epilepsy in children in England: A retrospective database review. Batchelor H Eur J Pharm Biopharm; 2021 Jan; 158():365-370. PubMed ID: 33338602 [TBL] [Abstract][Full Text] [Related]
11. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007. Strickley RG J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227 [TBL] [Abstract][Full Text] [Related]
12. Orodispersible tablets for pediatric drug delivery: current challenges and recent advances. Wiedey R; Kokott M; Breitkreutz J Expert Opin Drug Deliv; 2021 Dec; 18(12):1873-1890. PubMed ID: 34822316 [TBL] [Abstract][Full Text] [Related]
13. Minitablets: new modality to deliver medicines to preschool-aged children. Thomson SA; Tuleu C; Wong IC; Keady S; Pitt KG; Sutcliffe AG Pediatrics; 2009 Feb; 123(2):e235-8. PubMed ID: 19171575 [TBL] [Abstract][Full Text] [Related]
14. Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study. Kluk A; Sznitowska M; Brandt A; Sznurkowska K; Plata-Nazar K; Mysliwiec M; Kaminska B; Kotlowska H Int J Pharm; 2015 May; 485(1-2):1-6. PubMed ID: 25735666 [TBL] [Abstract][Full Text] [Related]
15. [Oral dosage forms for children: acceptability and palatability]. Kojima J Yakugaku Zasshi; 2015; 135(2):245-7. PubMed ID: 25747220 [TBL] [Abstract][Full Text] [Related]
16. The Development of Minitablets for a Pediatric Dosage Form for a Combination Therapy. Zhang D; Rumondor ACF; Zhu W; Colace T; Marota M; Mora J; Liu Z; Li Y J Pharm Sci; 2020 Dec; 109(12):3590-3597. PubMed ID: 32882230 [TBL] [Abstract][Full Text] [Related]
17. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review. Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378 [TBL] [Abstract][Full Text] [Related]
18. An introduction to fast dissolving oral thin film drug delivery systems: a review. Kathpalia H; Gupte A Curr Drug Deliv; 2013 Dec; 10(6):667-84. PubMed ID: 24274635 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study. Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177 [TBL] [Abstract][Full Text] [Related]
20. Atomic layer deposition-A novel method for the ultrathin coating of minitablets. Hautala J; Kääriäinen T; Hoppu P; Kemell M; Heinämäki J; Cameron D; George S; Juppo AM Int J Pharm; 2017 Oct; 531(1):47-58. PubMed ID: 28802795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]